Tokyo Tape
Sign in
← Medinet

Quarterly report · Q1

2370.TEDINET S100SUKD
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥248m2023-10-01 → 2023-12-31StandaloneNet sales
Revenue¥662m2022-10-01 → 2023-09-30StandaloneNet sales (5-year summary)
Revenue¥185m2022-10-01 → 2022-12-31StandaloneNet sales
Operating income−¥294m2023-10-01 → 2023-12-31StandaloneOperating income
Operating income−¥325m2022-10-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥292m2023-10-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥1.4bn2022-10-01 → 2023-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥324m2022-10-01 → 2022-12-31StandaloneOrdinary income
Profit before tax−¥292m2023-10-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥324m2022-10-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥293m2023-10-01 → 2023-12-31StandaloneProfit loss
Net income−¥1.4bn2022-10-01 → 2023-09-30StandaloneNet income loss (5-year summary)
Net income−¥326m2022-10-01 → 2022-12-31StandaloneProfit loss
Total assets¥6.3bnat 2023-12-31StandaloneAssets
Total assets¥5.6bnat 2023-09-30StandaloneAssets
Total assets¥5.5bnat 2022-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥549mat 2023-12-31StandaloneLiabilities
Total liabilities¥590mat 2023-09-30StandaloneLiabilities
Net assets / equity¥5.8bnat 2023-12-31StandaloneNet assets
Net assets / equity¥5.0bnat 2023-09-30StandaloneNet assets
Net assets / equity¥5.0bnat 2022-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥5.0bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥4.4bnat 2023-09-30StandaloneCash and deposits
EPS (basic)¥-1.22023-10-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.652022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.542022-10-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio91.3%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.2%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued253,510,757at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued232,160,757at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2023-12-31−¥147m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2023-10-01 → 2023-12-31¥56,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2023-10-01 → 2023-12-31¥56,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2023-10-01 → 2023-12-31−¥115m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2023-10-01 → 2023-12-31¥248m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2023-10-01 → 2023-12-31¥248m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2023-10-01 → 2023-12-31−¥32m
—segment totalrevenue2023-10-01 → 2023-12-31¥248m
—segment totalrevenue external2023-10-01 → 2023-12-31¥248m
—segment totalsegment profit2023-10-01 → 2023-12-31−¥147m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥161m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥107m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥57m
—segment totalrevenue2022-10-01 → 2022-12-31¥185m
—segment totalrevenue external2022-10-01 → 2022-12-31¥185m
—segment totalsegment profit2022-10-01 → 2022-12-31−¥164m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 307
ItemContextValueUnit
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember50214000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember18323000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember10657000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember61723000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember30694000JPY
Other clPrior1YearInstant_NonConsolidatedMember211574000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember181328000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember346838000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember272895000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember158146000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember158646000JPY
Provision for share based payments nclPrior1YearInstant_NonConsolidatedMember19133000JPY
Provision for share based payments nclCurrentQuarterInstant_NonConsolidatedMember25763000JPY
Other nclPrior1YearInstant_NonConsolidatedMember66085000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember91321000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember243365000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember275731000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember590203000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember548626000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember5736788000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember6238555000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember577808000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember1079574000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-1437950000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1730588000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-4000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-4000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember4876641000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember5587537000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember147029000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember205692000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember147029000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember205692000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember20270000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember6819000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember5043941000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember5800050000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5634145000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember6348677000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember185153000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember248236000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember138904000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember171842000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember46248000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember76393000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember371747000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember370302000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-325498000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-293909000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember1719000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-09-30pass rounding
balance sheet identitynon_consolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-10-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass